Win a $50,000 3D I/O Pro™ research grant from Alpenglow

Written By Guest User

Alpenglow Biosciences has developed the 3D I/O Pro™ assay to quantitatively assess tissue heterogeneity in the study of immuno-oncology, disease pathogenesis, and treatment response. To accelerate the development of novel therapeutics and next generation research in the important field of immuno-oncology, Alpenglow is launching a $50,000 research grant program, open to scientists worldwide, to leverage the 3D I/O Pro™ assay to unlock novel biological insights with 3D spatial biology.

Learn more about the research program and how the 3D I/O Pro™ assay can help accelerate your drug discovery and clinical programs.  3D I/O Pro™ assay is for Research Use Only (RUO).  Not for use in diagnostic procedures.  

Application Deadline: Wednesday, April 24, 2024

Guest User
Previous

Alpenglow Biosciences Secures $24M+ in ARPA-H and NIH Contracts to Revolutionize Cancer and Prostate Diagnostics
Next

Alpenglow Biosciences Announces Immediate Availability of 3D Derm Score Assay for Research into complex diseases of the skin